Afya Stock Forecast, Price & News

-0.06 (-0.27 %)
(As of 04/13/2021 12:00 AM ET)
Today's Range
Now: $22.04
50-Day Range
MA: $21.00
52-Week Range
Now: $22.04
Volume183,965 shs
Average Volume210,057 shs
Market Capitalization$1.98 billion
P/E Ratio30.61
Dividend YieldN/A
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil and mechanical engineering, industrial engineering, dentistry, pedagogy, nutrition, physiotherapy, psychology, architecture, veterinary medicine, and others. In addition, the company provides distance learning residency preparatory courses through its online platform; and develops and sells printed and digital medical education content. As of December 31, 2019, it operated a network of 19 undergraduate and graduate medical school campuses consisted of 12 operating units and seven approved units. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
Afya logo

Industry, Sector and Symbol

Industry Educational services
Current SymbolNASDAQ:AFYA
Year FoundedN/A



Sales & Book Value

Annual Sales$182.42 million
Cash Flow$0.74 per share
Book Value$5.97 per share


Net Income$39 million


Market Cap$1.98 billion
Next Earnings Date5/27/2021 (Estimated)
OptionableNot Optionable


Afya Limited Announces Medical Harbour Acquisition
April 8, 2021 |
Afya (AFYA) Scheduled to Post Earnings on Thursday
April 1, 2021 |
See More Headlines


Overall MarketRank

1.39 out of 5 stars

Consumer Discretionary Sector

167th out of 572 stocks

Educational Services Industry

21st out of 63 stocks

Analyst Opinion: 2.3Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 2.5 5 -4 -3 -2 -1 -
-0.06 (-0.27 %)
(As of 04/13/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AFYA News and Ratings via Email

Sign-up to receive the latest news and ratings for AFYA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Afya (NASDAQ:AFYA) Frequently Asked Questions

Is Afya a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Afya in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Afya stock.
View analyst ratings for Afya
or view top-rated stocks.

What stocks does MarketBeat like better than Afya?

Wall Street analysts have given Afya a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Afya wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Afya?

Afya saw a decrease in short interest during the month of February. As of February 26th, there was short interest totaling 804,300 shares, a decrease of 30.7% from the February 11th total of 1,160,000 shares. Based on an average daily volume of 241,600 shares, the short-interest ratio is currently 3.3 days.
View Afya's Short Interest

When is Afya's next earnings date?

Afya is scheduled to release its next quarterly earnings announcement on Thursday, May 27th 2021.
View our earnings forecast for Afya

How were Afya's earnings last quarter?

Afya Limited (NASDAQ:AFYA) released its quarterly earnings data on Wednesday, April, 7th. The company reported $0.89 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $1.58 by $0.69. The firm had revenue of $64.01 million for the quarter. Afya had a trailing twelve-month return on equity of 13.38% and a net margin of 26.75%.
View Afya's earnings history

How has Afya's stock price been impacted by Coronavirus (COVID-19)?

Afya's stock was trading at $18.94 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AFYA shares have increased by 16.4% and is now trading at $22.04.
View which stocks have been most impacted by COVID-19

What price target have analysts set for AFYA?

6 Wall Street analysts have issued 12 month price targets for Afya's stock. Their forecasts range from $21.50 to $34.00. On average, they expect Afya's share price to reach $27.53 in the next twelve months. This suggests a possible upside of 24.9% from the stock's current price.
View analysts' price targets for Afya
or view top-rated stocks among Wall Street analysts.

Who are Afya's key executives?

Afya's management team includes the following people:
  • Mr. Virgilio Deloy Capobianco Gibbon, Chief Exec. Officer (Age 45)
  • Mr. Luis Andre Carpintero Blanco, Chief Financial Officer (Age 48)
  • Renata Couto, Investor Relations Exec. Mang.
  • Mr. Julio Eduardo Razente de Angeli, VP of Continuing Education & Innovation (Age 48)

Who are some of Afya's key competitors?

What other stocks do shareholders of Afya own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Afya investors own include Honeywell International (HON), Pfizer (PFE), Cisco Systems (CSCO), The Procter & Gamble (PG), Raytheon Technologies (RTX), Abbott Laboratories (ABT), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA) and CSX (CSX).

When did Afya IPO?

(AFYA) raised $233 million in an IPO on Friday, July 19th 2019. The company issued 13,700,000 shares at $16.00-$18.00 per share. BofA Merrill Lynch, Goldman Sachs, UBS Investment Bank, Itaú BBA, Morgan Stanley, BTG and Pactual XP Investments served as the underwriters for the IPO.

What is Afya's stock symbol?

Afya trades on the NASDAQ under the ticker symbol "AFYA."

How do I buy shares of Afya?

Shares of AFYA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Afya's stock price today?

One share of AFYA stock can currently be purchased for approximately $22.04.

How much money does Afya make?

Afya has a market capitalization of $1.98 billion and generates $182.42 million in revenue each year. The company earns $39 million in net income (profit) each year or $0.70 on an earnings per share basis.

How many employees does Afya have?

Afya employs 3,369 workers across the globe.

What is Afya's official website?

The official website for Afya is

Where are Afya's headquarters?

Afya is headquartered at ALAMEDA OSCAR NIEMEYER NO 119 SALA 504 VILA DA SERRA, NOVA LIMA D5, .

How can I contact Afya?

Afya's mailing address is ALAMEDA OSCAR NIEMEYER NO 119 SALA 504 VILA DA SERRA, NOVA LIMA D5, . The company can be reached via phone at 55-31-3515-7550 or via email at [email protected]

This page was last updated on 4/13/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.